Millstone Evans Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.3K Hold
10
﹤0.01% 669
2026
Q1
$4.8K Hold
10
﹤0.01% 656
2025
Q4
$5.62K Hold
10
﹤0.01% 631
2025
Q3
$5.14K Buy
10
+5
+100% +$2.18K ﹤0.01% 628
2025
Q2
$1.57K Buy
+5
New +$1.5K ﹤0.01% 694

Other funds holding MEDP

Millstone Evans Group's MEDP Position: Q2 2026 in Review

Millstone Evans Group held its Medpace (MEDP) position steady in Q2 2026 at 10 shares worth $5.3K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Millstone Evans Group first reported a position in MEDP in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.62K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Millstone Evans Group held 10 shares of Medpace worth $5.3K as of Q2 2026.
  • Millstone Evans Group left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Millstone Evans Group's portfolio in Q2 2026, its #669 holding.
  • Millstone Evans Group first reported a position in Medpace in Q2 2025 and has held it in 5 quarters since.
  • Millstone Evans Group's Medpace position peaked at $5.62K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.